Cargando…

OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism

Disclosure: M.A. Grytaas: None. P. Methlie: None. I. Marinelli: None. E. Zavala: None. M. Øksnes: None. T. Upton: None. K. Simunkova: None. D.A. Vassiliadi: None. K. Løvås: None. S. Bensing: None. I. Botusan: None. K. Berinder: None. G.M. Russell: None. G. Ueland: None. O. Kampe: None. S. Tsagarakis...

Descripción completa

Detalles Bibliográficos
Autores principales: Aardal Grytaas, Marianne, Methlie, Paal, Marinelli, Isabella, Zavala, Eder, Øksnes, Marianne, Upton, Thomas, Simunkova, Katerina, Argyro Vassiliadi, Dimitra, Løvås, Kristian, Bensing, Sofie, Botusan, Ileana, Berinder, Katarina, Russell, Georgina M, Ueland, Grethe, Kampe, Olle, Tsagarakis, Stylianos, Louis Lightman, Stafford, Sverre Husebye, Eystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554187/
http://dx.doi.org/10.1210/jendso/bvad114.574
_version_ 1785116352424443904
author Aardal Grytaas, Marianne
Methlie, Paal
Marinelli, Isabella
Zavala, Eder
Øksnes, Marianne
Upton, Thomas
Simunkova, Katerina
Argyro Vassiliadi, Dimitra
Løvås, Kristian
Bensing, Sofie
Botusan, Ileana
Berinder, Katarina
Russell, Georgina M
Ueland, Grethe
Kampe, Olle
Tsagarakis, Stylianos
Louis Lightman, Stafford
Sverre Husebye, Eystein
author_facet Aardal Grytaas, Marianne
Methlie, Paal
Marinelli, Isabella
Zavala, Eder
Øksnes, Marianne
Upton, Thomas
Simunkova, Katerina
Argyro Vassiliadi, Dimitra
Løvås, Kristian
Bensing, Sofie
Botusan, Ileana
Berinder, Katarina
Russell, Georgina M
Ueland, Grethe
Kampe, Olle
Tsagarakis, Stylianos
Louis Lightman, Stafford
Sverre Husebye, Eystein
author_sort Aardal Grytaas, Marianne
collection PubMed
description Disclosure: M.A. Grytaas: None. P. Methlie: None. I. Marinelli: None. E. Zavala: None. M. Øksnes: None. T. Upton: None. K. Simunkova: None. D.A. Vassiliadi: None. K. Løvås: None. S. Bensing: None. I. Botusan: None. K. Berinder: None. G.M. Russell: None. G. Ueland: None. O. Kampe: None. S. Tsagarakis: None. S.L. Lightman: None. E.S. Husebye: None. Background: Primary aldosteronism (PA) is the most common cause of secondary hypertension but is grossly underdiagnosed. Early detection, accurate discrimination between unilateral and bilateral PA and appropriate treatment are vital to prevent cardiovascular and renal complications. The current workup however is a cumbersome, multistep process that may not detect dynamic aldosterone variability or nocturnal hypersecretion. Furthermore, subtype determination with adrenal venous sampling is invasive and technically challenging. Novel dynamic 24-hour steroid profiling may represent a major step forward in the diagnostics and subtyping of PA. Aim: To assess 24-hour rhythmicity of aldosterone and metabolites in PA, and to develop a novel dynamic diagnostic tool to discriminate PA from healthy subjects (HS), using tissue microdialysis. Material and methods: Twenty-minute frequency microdialysis fractions were collected over 24 hours from 64 ambulatory patients with PA (26 bilateral, 24 unilateral, 14 with undetermined subtype) using the U-Rhythm sampler followed by multiplex hormone assay liquid chromatography tandem mass spectrometry (LC-MS/MS). Sixteen patients subsequently treated with adrenalectomy for unilateral PA had additional postoperative samplings. Microdialysis samplings from 214 HS were used as controls. We calculated statistical distributions of dynamic biomarkers of abnormality, and developed a machine learning classifier that discriminates PA from HS. Results: Although there were large interindividual variations, PA patients did show a disturbed circadian rhythmicity of aldosterone compared with HS, including some with multiple very high ultradian spikes. Unilateral PA had higher aldosterone spikes and more disturbed rhythmicity compared with bilateral PA. A profound reduction of aldosterone levels and normalisation of rhythmicity was seen post adrenalectomy. Applying a Random Forest classifier in a subgroup of 20 PA patients, 82% specificity and 85% sensibility were achieved to discriminate PA from HS. Our analysis also suggests 18-hydroxycortisol as the most discriminative dynamic biomarker. Conclusions: We demonstrate for the first time circadian and ultradian rhythms of aldosterone in a large cohort of PA compared with HS. Based on our preliminary results, dynamic 24-hour samplings may provide a novel method for diagnosing and subtyping PA, and assess biochemical cure after adrenalectomy. Presentation: Thursday, June 15, 2023
format Online
Article
Text
id pubmed-10554187
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105541872023-10-06 OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism Aardal Grytaas, Marianne Methlie, Paal Marinelli, Isabella Zavala, Eder Øksnes, Marianne Upton, Thomas Simunkova, Katerina Argyro Vassiliadi, Dimitra Løvås, Kristian Bensing, Sofie Botusan, Ileana Berinder, Katarina Russell, Georgina M Ueland, Grethe Kampe, Olle Tsagarakis, Stylianos Louis Lightman, Stafford Sverre Husebye, Eystein J Endocr Soc Cardiovascular Endocrinology Disclosure: M.A. Grytaas: None. P. Methlie: None. I. Marinelli: None. E. Zavala: None. M. Øksnes: None. T. Upton: None. K. Simunkova: None. D.A. Vassiliadi: None. K. Løvås: None. S. Bensing: None. I. Botusan: None. K. Berinder: None. G.M. Russell: None. G. Ueland: None. O. Kampe: None. S. Tsagarakis: None. S.L. Lightman: None. E.S. Husebye: None. Background: Primary aldosteronism (PA) is the most common cause of secondary hypertension but is grossly underdiagnosed. Early detection, accurate discrimination between unilateral and bilateral PA and appropriate treatment are vital to prevent cardiovascular and renal complications. The current workup however is a cumbersome, multistep process that may not detect dynamic aldosterone variability or nocturnal hypersecretion. Furthermore, subtype determination with adrenal venous sampling is invasive and technically challenging. Novel dynamic 24-hour steroid profiling may represent a major step forward in the diagnostics and subtyping of PA. Aim: To assess 24-hour rhythmicity of aldosterone and metabolites in PA, and to develop a novel dynamic diagnostic tool to discriminate PA from healthy subjects (HS), using tissue microdialysis. Material and methods: Twenty-minute frequency microdialysis fractions were collected over 24 hours from 64 ambulatory patients with PA (26 bilateral, 24 unilateral, 14 with undetermined subtype) using the U-Rhythm sampler followed by multiplex hormone assay liquid chromatography tandem mass spectrometry (LC-MS/MS). Sixteen patients subsequently treated with adrenalectomy for unilateral PA had additional postoperative samplings. Microdialysis samplings from 214 HS were used as controls. We calculated statistical distributions of dynamic biomarkers of abnormality, and developed a machine learning classifier that discriminates PA from HS. Results: Although there were large interindividual variations, PA patients did show a disturbed circadian rhythmicity of aldosterone compared with HS, including some with multiple very high ultradian spikes. Unilateral PA had higher aldosterone spikes and more disturbed rhythmicity compared with bilateral PA. A profound reduction of aldosterone levels and normalisation of rhythmicity was seen post adrenalectomy. Applying a Random Forest classifier in a subgroup of 20 PA patients, 82% specificity and 85% sensibility were achieved to discriminate PA from HS. Our analysis also suggests 18-hydroxycortisol as the most discriminative dynamic biomarker. Conclusions: We demonstrate for the first time circadian and ultradian rhythms of aldosterone in a large cohort of PA compared with HS. Based on our preliminary results, dynamic 24-hour samplings may provide a novel method for diagnosing and subtyping PA, and assess biochemical cure after adrenalectomy. Presentation: Thursday, June 15, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10554187/ http://dx.doi.org/10.1210/jendso/bvad114.574 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Cardiovascular Endocrinology
Aardal Grytaas, Marianne
Methlie, Paal
Marinelli, Isabella
Zavala, Eder
Øksnes, Marianne
Upton, Thomas
Simunkova, Katerina
Argyro Vassiliadi, Dimitra
Løvås, Kristian
Bensing, Sofie
Botusan, Ileana
Berinder, Katarina
Russell, Georgina M
Ueland, Grethe
Kampe, Olle
Tsagarakis, Stylianos
Louis Lightman, Stafford
Sverre Husebye, Eystein
OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism
title OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism
title_full OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism
title_fullStr OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism
title_full_unstemmed OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism
title_short OR02-03 Twenty-four-hour Tissue Microdialysis Of Aldosterone And Metabolites In Primary Aldosteronism
title_sort or02-03 twenty-four-hour tissue microdialysis of aldosterone and metabolites in primary aldosteronism
topic Cardiovascular Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554187/
http://dx.doi.org/10.1210/jendso/bvad114.574
work_keys_str_mv AT aardalgrytaasmarianne or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT methliepaal or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT marinelliisabella or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT zavalaeder or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT øksnesmarianne or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT uptonthomas or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT simunkovakaterina or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT argyrovassiliadidimitra or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT løvaskristian or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT bensingsofie or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT botusanileana or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT berinderkatarina or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT russellgeorginam or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT uelandgrethe or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT kampeolle or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT tsagarakisstylianos or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT louislightmanstafford or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism
AT sverrehusebyeeystein or0203twentyfourhourtissuemicrodialysisofaldosteroneandmetabolitesinprimaryaldosteronism